ICON Price to Free Cash Flow Ratio 2012-2026 | ICLR
Historical price to free cash flow ratio values for ICON (ICLR) since 2012.
| ICON Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-09-15 | 172.45 | 15.23 | |
| 2026-06-30 | 173.71 | $11.32 | 15.34 |
| 2026-03-31 | 110.66 | $9.72 | 11.38 |
| 2025-12-31 | 182.22 | $10.92 | 16.69 |
| 2025-09-30 | 175.00 | $12.19 | 14.36 |
| 2025-06-30 | 145.45 | $12.13 | 11.99 |
| 2025-03-31 | 174.99 | $12.83 | 13.64 |
| 2024-12-31 | 209.71 | $13.47 | 15.57 |
| 2024-09-30 | 287.31 | $14.79 | 19.42 |
| 2024-06-30 | 313.47 | $14.24 | 22.01 |
| 2024-03-31 | 335.95 | $14.14 | 23.76 |
| 2023-12-31 | 283.07 | $12.34 | 22.95 |
| 2023-09-30 | 246.25 | $6.22 | 39.60 |
| 2023-06-30 | 250.20 | $4.60 | 54.41 |
| 2023-03-31 | 213.59 | $4.40 | 48.56 |
| 2022-12-31 | 194.25 | $5.11 | 38.04 |
| 2022-09-30 | 183.78 | $11.21 | 16.39 |
| 2022-06-30 | 216.70 | $11.09 | 19.53 |
| 2022-03-31 | 243.22 | $11.38 | 21.38 |
| 2021-12-31 | 309.70 | $10.80 | 28.67 |
| 2021-09-30 | 262.02 | $9.52 | 27.52 |
| 2021-06-30 | 206.71 | $9.47 | 21.82 |
| 2021-03-31 | 196.37 | $9.39 | 20.91 |
| 2020-12-31 | 194.98 | $9.89 | 19.71 |
| 2020-09-30 | 191.09 | $8.63 | 22.15 |
| 2020-06-30 | 168.46 | $9.36 | 18.01 |
| 2020-03-31 | 136.00 | $7.48 | 18.18 |
| 2019-12-31 | 172.23 | $6.66 | 25.86 |
| 2019-09-30 | 147.34 | $5.26 | 27.99 |
| 2019-06-30 | 153.97 | $4.70 | 32.74 |
| 2019-03-31 | 136.58 | $5.05 | 27.03 |
| 2018-12-31 | 129.21 | $4.02 | 32.14 |
| 2018-09-30 | 153.75 | $4.81 | 31.98 |
| 2018-06-30 | 132.53 | $4.50 | 29.47 |
| 2018-03-31 | 118.14 | $4.03 | 29.34 |
| 2017-12-31 | 112.15 | $6.17 | 18.18 |
| 2017-09-30 | 113.88 | $6.71 | 16.97 |
| 2017-06-30 | 97.79 | $5.64 | 17.35 |
| 2017-03-31 | 79.72 | $5.65 | 14.11 |
| 2016-12-31 | 75.20 | $3.84 | 19.58 |
| 2016-09-30 | 77.37 | $3.46 | 22.38 |
| 2016-06-30 | 70.01 | $3.76 | 18.60 |
| 2016-03-31 | 75.10 | $3.91 | 19.22 |
| 2015-12-31 | 77.70 | $3.80 | 20.43 |
| 2015-09-30 | 70.97 | $3.19 | 22.28 |
| 2015-06-30 | 67.30 | $3.73 | 18.04 |
| 2015-03-31 | 70.53 | $2.52 | 28.02 |
| 2014-12-31 | 50.99 | $2.22 | 23.01 |
| 2014-09-30 | 57.23 | $2.58 | 22.17 |
| 2014-06-30 | 47.11 | $1.57 | 29.95 |
| 2014-03-31 | 47.55 | $2.59 | 18.38 |
| 2013-12-31 | 40.42 | $3.05 | 13.24 |
| 2013-09-30 | 40.93 | $1.66 | 24.72 |
| 2013-06-30 | 35.43 | $1.45 | 24.49 |
| 2013-03-31 | 32.29 | $1.45 | 22.34 |
| 2012-12-31 | 27.76 | $1.36 | 20.43 |
| 2012-09-30 | 24.37 | $1.75 | 13.90 |
| 2012-06-30 | 22.53 | $1.09 | 20.74 |
| 2012-03-31 | 21.22 | $0.83 | 25.61 |
| 2011-12-31 | 17.11 | $-0.25 | 0.00 |
| 2011-09-30 | 16.08 | $-0.28 | 0.00 |
| 2011-06-30 | 23.56 | $-0.05 | 0.00 |
| 2011-03-31 | 21.59 | $0.62 | 34.63 |
| 2010-12-31 | 21.90 | $0.93 | 23.59 |
| 2010-09-30 | 21.62 | $1.33 | 16.28 |
| 2010-06-30 | 28.89 | $2.38 | 12.12 |
| 2010-03-31 | 26.41 | $3.53 | 7.49 |
| 2009-12-31 | 21.73 | $3.68 | 5.90 |
| 2009-09-30 | 24.49 | $2.57 | 9.52 |
| 2009-06-30 | 21.58 | $2.21 | 9.75 |
| 2009-03-31 | 16.15 | $0.98 | 16.47 |
| 2008-12-31 | 19.69 | $0.22 | 88.02 |
| 2008-09-30 | 38.25 | $0.48 | 79.24 |
| 2008-06-30 | 37.76 | $-0.47 | 0.00 |
| 2008-03-31 | 32.45 | $-0.76 | 0.00 |
| 2007-12-31 | 30.93 | $-0.54 | 0.00 |
| 2007-09-30 | 25.52 | $-0.41 | 0.00 |
| 2007-06-30 | 21.87 | $-0.21 | 0.00 |
| 2007-03-31 | 21.30 | $0.06 | 342.44 |
| 2006-12-31 | 18.85 | $0.32 | 58.58 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.935B | $8.251B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.882B | 25.03 |
| CVS Health (CVS) | United States | $122.206B | 12.19 |
| HCA Healthcare (HCA) | United States | $92.119B | 14.32 |
| Elevance Health (ELV) | United States | $92.005B | 14.44 |
| Cencora (COR) | United States | $62.254B | 19.02 |
| Natera (NTRA) | United States | $49.267B | 0.00 |
| Labcorp Holdings (LH) | United States | $25.572B | 18.03 |
| Viatris (VTRS) | United States | $19.136B | 6.61 |
| Medpace Holdings (MEDP) | United States | $16.619B | 34.90 |
| DiDi Global (DIDIY) | China | $16.275B | 178.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.114B | 0.00 |
| Solventum (SOLV) | United States | $15.290B | 12.65 |
| Revvity (RVTY) | United States | $14.338B | 24.02 |
| Charles River Laboratories (CRL) | United States | $13.038B | 27.59 |
| BrightSpring Health Services (BTSG) | United States | $11.931B | 41.02 |
| Avantor (AVTR) | United States | $10.254B | 18.49 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| HealthEquity (HQY) | United States | $7.944B | 25.89 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.362B | 72.36 |
| PACS (PACS) | United States | $7.051B | 23.70 |
| Sonic Healthcare (SKHHY) | Australia | $6.687B | 0.00 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.282B | 23.76 |
| MiniMed (MMED) | United States | $6.181B | 0.00 |
| Sotera Health (SHC) | United States | $5.285B | 21.79 |
| Concentras Parent (CON) | United States | $4.566B | 22.52 |
| Organon (OGN) | United States | $3.585B | 4.55 |
| CareDx (CDNA) | United States | $2.709B | 308.06 |
| Alignment Healthcare (ALHC) | United States | $2.684B | 68.11 |
| GeneDx Holdings (WGS) | United States | $2.676B | 249.28 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.187B | 12.81 |
| Establishment Labs Holdings (ESTA) | United States | $2.143B | 0.00 |
| Progyny (PGNY) | United States | $2.137B | 30.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.013B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.914B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.838B | 70.20 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.607B | 0.00 |
| Ardent Health (ARDT) | United States | $1.552B | 8.87 |
| Agilon Health (AGL) | United States | $1.551B | 0.00 |
| Nutex Health (NUTX) | United States | $1.486B | 8.52 |
| InnovAge Holding (INNV) | United States | $1.470B | 0.00 |
| Omada Health (OMDA) | United States | $1.255B | 256.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.220B | 23.73 |
| Teladoc Health (TDOC) | United States | $1.181B | 0.00 |
| CryoPort (CYRX) | United States | $0.808B | 0.00 |
| GMR Solutions (GMRS) | United States | $0.716B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Forward Industries (FWDI) | United States | $0.513B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.474B | 0.00 |
| SBC Medicals (SBC) | United States | $0.467B | 9.66 |
| Shoulder Innovations (SI) | United States | $0.382B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.47 |
| Embecta (EMBC) | United States | $0.297B | 2.57 |
| Biodesix (BDSX) | United States | $0.289B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.101B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.065B | 7.65 |
| Tevogen (TVGN) | United States | $0.049B | 0.00 |
| DocGo (DCGO) | United States | $0.037B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |